MAPT and Alzheimer disease: Patients with AD have significantly higher levels of tau tracer retention than CN individuals [25, 26, 35–37, 39, 40, 42, 44, 59] including in the inferior lateral temporal, posterior cingulate, and lateral parietal regions, with binding  matching the known regional deposition of tau pathology reported in histopathological studies [51, 60].